Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naïve to Nevirapine by Using Stochastic Simulations and a Mathematical Model
J. Virol. Gadhamsetty and Dixit 84: 10230

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Fig. S1 (Fits of our model to data from competitive growth assays for different mutants.)
    Fig. S2 (Comparisons of the relative fitness of viable mutants.)
    Fig. S3 (Expected frequencies of single and double mutants in cell-free viral RNA corresponding to the frequencies in proviral DNA shown in Fig. 6.)
    Fig. S4 (Expected frequencies of single and double mutants in cell-free viral RNA corresponding to the frequencies in proviral DNA shown in Fig. 7.)
    Fig. S5 (Expected frequencies of single and double mutants in cell-free viral RNA corresponding to the frequencies in proviral DNA shown in Fig. 8.)
    Fig. S6 (Expected frequencies of single, double, triple, and quadruple and quintuple mutants in cell-free viral RNA corresponding to the frequencies in proviral DNA shown in Fig. 9.)
    Fig. S7 (Expected frequencies of single and double mutants estimated from our simulations.)
    PDF file, 215K.